pharmaceutical investing Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab Platform
Heliostar Presents Q2 2026 Financial and Operating Results with Record Gold Production and Cash Balance
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR
